Skip to main content
Clinical Trials/CTRI/2023/06/053509
CTRI/2023/06/053509
Not yet recruiting
Phase 2

A single blind randomized placebo controlled clinical study to evaluate the effect of arjakadi vati in shukraghata vata with special reference to premature ejacualtion

DR Muttu mantesh hadapad0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
DR Muttu mantesh hadapad
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
DR Muttu mantesh hadapad

Eligibility Criteria

Inclusion Criteria

  • 1\. ejaculation prior to ten penile thrusts.
  • 2\. ejaculation before on or within one minute of the
  • sexual act after penetration
  • 3\. unable to satisfy partner in at least 50% the
  • coital incidences
  • 4\. unable to delay ejaculation till person wishes

Exclusion Criteria

  • 1\. the factor that affect the duration of
  • Excitement phase of sexual act such as novelity
  • of the partner or situation and the recent
  • frequency of sexual act is taken into account.
  • 2\. persons having very short post ejaculatory
  • refractory period
  • 3\. major psychiatric illness
  • 4\. subject with HTN and Uncontrolled DM
  • 5\. Structural Deformity like Cryptorchidism,
  • Varicocele, Hydrocele,etc.

Outcomes

Primary Outcomes

Not specified

Similar Trials